Orion Infusion Limited (DSE:ORIONINFU)
Bangladesh
· Delayed Price · Currency is BDT 309.40
-1.90 (-0.61%)
At close: Apr 28, 2026
Orion Infusion Revenue
Orion Infusion had revenue of 228.94M BDT in the quarter ending December 31, 2025, with 17.38% growth. This brings the company's revenue in the last twelve months to 665.43M, down -14.96% year-over-year. In the fiscal year ending June 30, 2025, Orion Infusion had annual revenue of 664.92M, down -19.64%.
Revenue (ttm)
665.43M
Revenue Growth
-14.96%
P/S Ratio
9.47
Revenue / Employee
1.18M
Employees
563
Market Cap
6.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 664.92M | -162.50M | -19.64% |
| Jun 30, 2024 | 827.42M | 17.26M | 2.13% |
| Jun 30, 2023 | 810.15M | -19.42M | -2.34% |
| Jun 30, 2022 | 829.57M | 102.17M | 14.05% |
| Jun 30, 2021 | 727.40M | -13.47M | -1.82% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orion Pharma | 3.12B |
| Navana Pharmaceuticals | 10.07B |
| Green Delta Insurance PLC. | 3.81B |
| Pragati Life Insurance | 6.82B |
| Dominage Steel Building Systems | 123.41M |
| Pioneer Insurance | 2.07B |
| ACI Formulations | 5.52B |
| IFAD Autos PLC. | 10.12B |